drugset / Trial / NCT06102720
Efficacy of Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Ischemic Stroke During Hospitalization
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is two-center, prospective, randomized, open-label, controlled, investigator-sponsored study that aims to investigate the efficacy of low-dose colchicine in preventing recurrent stroke in the patients with acute atherothrombotic minor-to-moderate ischemic stroke during hospitalization.
Timeline
- Start
- 2023-01-12
- Primary completion
- 2025-01-01
- Completion
- 2025-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clopidogrel | Small molecule | 75 mg | — |
| Subject | Colchicine | Small molecule | 0.5 mg | Oral |
| Background | Aspirin | Small molecule | 100 mg | — |